Christopher Owens, MD
Orthopaedic Surgery · Goshen, INNPI 1497911325
Payments from drug & device makers
Across 61 payments — averaging $90.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$4K
- Stryker$796
- Boehringer Ingelheim$208
- Johnson & Johnson$164
- Zimmer Biomet$155
- DJO, LLC$149
- plus $536 from 10 others
Across 2 payments — averaging $1575.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Linvatec Corporation$3K
What the payments were for
- Consulting fees$2,60047%
- Travel & lodging$4779%
- Food & beverage$2,36343%
- Education$781%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 13 | $3,510 |
| Stryker | 22 | $796 |
| Boehringer Ingelheim | 4 | $208 |
| Johnson & Johnson(2 entities) | 4 | $164 |
| Zimmer Biomet | 3 | $155 |
| DJO, LLC | 1 | $149 |
| Lilly USA, LLC | 1 | $121 |
| GSK | 1 | $107 |
| Janssen Scientific Affairs, LLC | 1 | $98 |
| Abbott | 4 | $63 |
| Bayer | 2 | $53 |
| UCB, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Orthofix Medical, Inc. | 1 | $15 |
| Biocomposites Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioBrace 23mm$3,025
- LINVATEC SHOULDER ARTHROSCOPY$1,110
- SHOULDER MANUAL INSTRUMENTS$1,000
- SPY-PHI SYSTEM$154
- LIVATEC KNEE PRESERVATION SYSTEM$150
- Viaflow$142
- INBONE$142
- AUGMENT INJECTABLE$142
- Persona$134
- JARDIANCE$125
- ZEPBOUND$121
- NUCALA$107
How this compares
$5,518 in reported general payments places this provider in the 50th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 69 | $1,100 |
| Celecoxib | 13 | $644 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $111 |
| Amoxicillin | 60 | $94 |
| Tramadol Hcl | 29 | $94 |
| Methylprednisolone | 14 | $65 |
| Meloxicam | 16 | $60 |
| Oxycodone Hcl | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Goshen
- Frank KolisekGreenwood$7.6M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4.1M
- John WilliamsFort Wayne$2.7M
- Alan McGeeFort Wayne$2.3M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Mark KlaassenElkhart$1.4M
- Micah SmithFort Wayne$1.2M
- Lindsey RolstonNew Castle$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.